The Power of Advertising.

My parents preferred Dan Rather. Sometimes they would watch Tom Brokaw deliver the news and only rarely did they settle for Peter Jennings. After dinner each night, we would retire to the main room in the house to watch the evening news. At my father’s side was a mug of steaming jasmine tea. My mother usually had a cup of hot water. I sat between them. I easily tucked my lanky nine year-old legs underneath me.

Though my eyes were fixed on the images flashing from the large metal box (”Dan Rather has nice hair”), my mind was elsewhere. I could not understand why my parents insisted on watching the news every night. I assumed it was part of a digestion ritual: Tea and TV.

The commercials, however, captured my attention.

C&R Clothiers, for many years, ran an advertisement where the camera slowly revolved around headless men wearing tailored suits. These men, visible only from the neck down, had their hands on their slim hips, adjusting their paisley neckties, and within the pockets of their pleated pants. In the background, a woman (and not Dinah Washington, who, incidentally, sounds a bit like Ella Fitzgerald) crooned

What a difference a day makes… twenty-four little hours….

Soon, my father and I began to mimic the woman with maudlin falsetto voices. That was the only line we could ever recite, as that was the only line the woman ever sang in the commercial. After those twenty-four little hours, a masculine voice provided a voiceover about the quality clothing of C&R Clothiers and how you—yes, you!—could look as good as these men in twenty-four little hours.

Google tells me that C&R Clothiers went bankrupt in 1992.

Jamie Cullum covers “What a Difference a Day Makes” on his (fun) album Twentysomething. Within the first few bars of the song, I automatically think of slim men in tweed suits. The words “C&R Clothing” in script font appear in my mind and I remember those temperate days in Southern California, President Reagan’s toothy grin, and legwarmers.

This is the power of advertising.

Janssen has released a “new” antipsychotic medication called Invega (generic name paliperidone), which is the supposedly the “new and improved” version of Risperdal (generic name risperidone). Coincidentally, risperidone is about go off patent. (Clinical Psychology and Psychiatry has covered this issue nicely, as has Dr. Carlat.)

The advertisements (and website) for Invega features a young, black male. In some ads, he is looking up, eyes closed, against a background of hand-drawn, anguished faces. The caption reads: “Do You Choose a Powerful Antipsychotic for His Mind That Also Considers His Body?” In other ads, he smiles warmly at the camera. Or is carrying a bag of groceries alongside a young, white female, who is also carrying a bag of groceries.

As far as I know, this is the only advertisement for antipsychotic medication that features a non-white person.

I wonder how this will affect prescribing practices. Will physicians and psychiatrists preferentially (and perhaps unconsciously) prescribe Invega more often to black individuals than to white people? How does this advertisement affect the stereotypes psychiatrists may hold in their minds about who has psychotic disorders? Is there a marketing scheme behind this ploy? In other branches of medicine, researchers have conducted studies about medications that may be more efficacious in black individuals (the condition that jumps to mind is high blood pressure). Because no one totally knows how antipsychotics work (there are theories, but no one knows definitively, even if he pontificates otherwise), there is no evidence to use one antipsychotic over another in a specific ethnic population…

… unless prescribers somehow associate one medication with one population through advertising and, over time, interpret this as “evidence”.

The people who know the most about human behavior and how to influence it are not psychiatrists or psychologists. They’re marketers.


10 Nov 2007 |



4 comments »


You know, advertising can be annoying, but it’s not that bad. (I say this having started running Google text ads recently.) Advertising tries to get the word out about something that people might want, but don’t know you have it. Same goes for newspaper listings, craigslist, what-have-you.

What’s bad is so-called “marketing”. Once upon a time, (hypothetically) it referred to determining what the market was for a product.

It is now dedicated almost entirely to *generating* a market — making people want something.

One of my favorite sites on the internet has an excellent section on anti-advertisement here. The English can be bad at times, I think because there are bunch of people on there for whom it is not a first language, but some of the insights and techniques are helpful.

Comment by Brock Tice | 10 Nov 2007 @ 9:32pm



Someday you will listen to the news and ignore the ads.

Comment by Greg P | 11 Nov 2007 @ 6:47am



Will physicians and psychiatrists preferentially (and perhaps unconsciously) prescribe Invega more often to black individuals than to white people?

Well if they’re smart, they’ll prescribe whatever doesn’t require a prior authorization, which will most likely be generic Risperdal. :) (See Focalin — dexmethylphenidate — for an analogous situation.) And then of course go from there if necessary.

That makes me wonder… As someone who’s interested in consult psychiatry, you’ll be working within the confines of a hospital most (all?) of the time, which means you’ll have a relatively set formulary of drugs to work within. Generally, physicians in hospitals don’t think or worry about whether drugs are covered or not covered by an insurer because they’re not dealing with a pharmacy benefits manager, whereas outpatient doctors most certainly do.

When we see med lists for discharged patients, they often boggle the mind because it’s completely different from what a non-hospitalist would do — often expensive, brand-name drugs across the board, because that’s what the in-house formulary often is.

Is cost and access a factor you consider when a patient is discharged? I would imagine this is particularly important for psychiatric patients, of whom a large percentage are on medicaid or other .gov-subsidized insurance…

Comment by RJS | 11 Nov 2007 @ 7:25am



Maybe they should get some marketers on board to help influence compliance practices in patients….”this is why you should stay on your meds even after you feel better”.

Comment by Dragonfly | 12 Nov 2007 @ 2:27am




Say something.

|